Partneringreview 2006 – Early stage: discovery, lead and preclinical provides an in depth view into the early stage deals and alliances announced in 2005, in a clear and accessible format.
The report analyzes deals announced by company, industry focus, and therapy focus. Every deal is fully categorized, includes a detailed description, and includes financials such as headline value, upfront and milestone payments, where disclosed.
Included in early stage deals are discovery, lead molecule, and preclinical (IND) deals.
Each deal is annotated with a deal number, such as #43. This number links to the full deal in the deal listing at the rear of each report. When using the PDF format in Acrobat Reader, simply click on the number to move around the report.
Other selected research from the 'Business Development' category:
Partneringdesk Schering AG and Company Deals Briefing
Pricing and Reimbursement Strategies for Diagnostics: Overcoming reimbursement issues and navigating the regulatory environment
Other selected research from the 'Markets' category:
The Womens Health Outlook to 2008: Market and pipeline analysis of major female disorders
Global Pharmaceuticals